Changli Wang

机构：Academy of Medical Sciences, Second Military Medical University, Shandong Tumor Hospital, Changhai Hospital, Shandong First Medical University · ORCID：0000-0003-3508-2918

发表论文 47 篇 · 总被引 853 次 · h-index 15

代表论文

• Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial (2024 · The Lancet Respiratory Medicine · 被引 121)
• Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair (2024 · Scientific Reports · 被引 46)
• A review of the research progress on Pinellia ternata (Thunb.) Breit.: Botany, traditional uses, phytochemistry, pharmacology, toxicity and quality control (2023 · Heliyon · 被引 45)
• Exogenous acetate attenuates inflammatory responses through HIF-1α-dependent glycolysis regulation in macrophage (2024 · Cellular and Molecular Life Sciences · 被引 25)
• Theta/beta ratio in EEG correlated with attentional capacity assessed by Conners Continuous Performance Test in children with ADHD (2024 · Frontiers in Psychiatry · 被引 24)
• Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis (2025 · Cellular & Molecular Biology Letters · 被引 18)